Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MALT1 antisense RNA 1 (MALT1-AS1) is a long non-coding natural antisense RNA located at the *MALT1* gene locus. While little direct functional data exists for MALT1-AS1 specifically, it is analogous to other antisense lncRNAs at gene loci that often regulate the expression, alternative splicing, or maturation of their sense counterparts. For well-studied loci, natural antisense transcripts have been shown to influence RNA processing and gene regulation by forming RNA–RNA duplexes with the sense transcript or by recruiting regulatory protein complexes[5]. No established role exists for MALT1-AS1 as a *direct therapeutic target or receptor*, nor are there drugs or small molecules known to act on it. Its classification is as a *long non-coding antisense RNA*, *not a protein, enzyme, receptor, transporter, or signaling molecule*. The currently available data do not implicate MALT1-AS1 in canonical disease pathways, though modulation of MALT1 expression (which is therapeutically targeted in lymphomas[2][4][7][1]) could indirectly relate to its function. **Note:** - The references to mechanisms, functions, and disease roles predominantly relate to MALT1 (the protein, a paracaspase important in immune signaling and lymphoma), not MALT1-AS1[1][2][4][7][5]. Carefully distinguish between the antisense lncRNA and the protein-coding gene when interpreting literature. - There is no published evidence that MALT1-AS1 is a receptor, enzyme, or direct drug target[5]. - No drugs, mechanisms of action for drugs, biomarkers, or safety concerns are reported specifically for MALT1-AS1. **Summary statement:** MALT1-AS1 is a long non-coding antisense RNA at the MALT1 locus. It may have regulatory roles at the RNA level, but it is *not* itself a therapeutic target or receptor, and no drugs, biomarkers, or clinical complications are currently associated with it. The target name and abbreviation are correct and reflective of the current gene nomenclature[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MALT1 antisense RNA 1 (MALT1-AS1).